Dunkley, A.J. orcid.org/0000-0002-2640-6004, Fitzpatrick, C., Gray, L.J. et al. (6 more authors) (2019) Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: a UK multi-site 12-month prospective observational study. Diabetes, Obesity and Metabolism, 21 (7). pp. 1585-1595. ISSN 1462-8902
Abstract
AIMS: To determine the incidence and severity of self-reported hypoglycaemia in a primary care population with type 2 diabetes. The study also aimed to compare incidence by treatment regimen. MATERIALS AND METHODS: A prospective observational study in 17 centres throughout the UK. Recruitment was based on treatment regimen (metformin, sulfonylurea, insulin or incretin-based therapy). Participants were asked to keep a blood glucose diary and self-report hypoglycaemia episodes (non-severe (self-treated) and severe (requiring external help), over a 12-month period. RESULTS: 325 participants were enrolled, of whom 274 (84%) returned ≥1 monthly diary. Overall, 39% reported experiencing hypoglycaemia; 32% recorded ≥1 symptomatic episode, 36% ≥1 non-severe and 7% ≥1 severe. By treatment, incidence (events per person/year) for any hypoglycaemia type was 4.39 for insulin, 2.34 sulfonylurea, 0.76 metformin and 0.56 incretin-based. Compared to metformin, risk of non-severe hypoglycaemia was around three times higher for participants on sulfonylureas and over five times higher for those on insulin (IRR 3.02 [1.76- 5.18], p<0.001, and IRR 5.96 [3.48-10.2], p<0.001, respectively). For severe episodes, the incidence for sulfonylurea (0.09) was similar to metformin (0.07) and incretin-based (0.07); for insulin the risk remained almost five times higher than metformin (incidence 0.32; IRR 4.55 [1.28-16.20], p=0.019). CONCLUSIONS: Hypoglycaemia represents a substantial burden for people with type 2 diabetes. Sulfonylureas and insulin are both associated with a risk of reported non-severe hypoglycaemia, but only insulin with severe episodes. This suggests the importance of the continued use of sulfonylureas in appropriate patients with type 2 diabetes.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2019 Wiley. This is an author produced version of a paper subsequently published in Diabetes, Obesity and Metabolism. Uploaded in accordance with the publisher's self-archiving policy. |
Keywords: | Hypoglycaemia; Incidence; Observational study; Primary care; Treatment regimen; Type 2 diabetes |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Sheffield Teaching Hospitals |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 18 Mar 2019 12:34 |
Last Modified: | 19 Nov 2021 13:40 |
Status: | Published |
Publisher: | Wiley |
Refereed: | Yes |
Identification Number: | 10.1111/dom.13690 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:143747 |